News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Pooled analysis ASSUREs seladelpar role in PBC
04 Dec 2024
byAudrey Abella
Results of the phase III ASSURE study support seladelpar – a novel first-in-class delpar (selective peroxisome proliferator-activated receptor delta agonist) – for the treatment of primary biliary cholangitis (PBC).
04 Dec 2024

Motherhood among breast cancer survivors: Studies provide reassuring evidence on breastfeeding
03 Dec 2024
byDr. Eva Blondeaux; Dr. Fedro Peccatori; Dr. Maria Alice Franzoi
For new mothers who have undergone breast cancer treatment, including those who harbour the BRCA gene mutation, breastfeeding appears to be a safe and viable option, posing no increased risk of recurrence or development of new breast cancers, according to new research.
03 Dec 2024

Why not metformin for long COVID in non-diabetics?
03 Dec 2024
byElvira Manzano
Metformin prescribed within a week of SARS-CoV-2 infection was associated with a 53-percent reduction in long COVID or death over 6 months in patients without diabetes or prediabetes, as shown in a simulation study presented at IDWeek 2024.
03 Dec 2024






